Condition: Tricuspid Valve Regurgitation · Heart Valve Diseases · Cardiovascular Diseases · Sponsor: TRiCares
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
This description comes directly from the study's public registry record.
Esther Gerteis · +41796015318 · gerteis@tricares.de
Always discuss trial participation with your own doctor first.
| Piedmont Healthcare Inc. | Atlanta, Georgia, United States | Recruiting |
| Northwestern | Chicago, Illinois, United States | Recruiting |
| University of Michigan Hospital and Health Systems | Ann Arbor, Michigan, United States | Recruiting |
| Minneapolis Heart Institute Foundation | Minneapolis, Minnesota, United States | Recruiting |
| Columbia University Medical Center/ NewYork Presbyterian Hospital | New York, New York, United States | Recruiting |
| Montefiore | The Bronx, New York, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| Medical University of South Carolina | Charleston, South Carolina, United States | Recruiting |
| St. Paul's Hospital | Vancouver, British Columbia, Canada | Recruiting |
| St. Michaels Hospital | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06506942